Zydus Cadila has agreed to convey down the value of its Covid-19 vaccine to Rs 265 a dose following persistent negotiations by the federal government however a ultimate deal is but to be reached, experiences stated on Sunday.
Zydus Cadila’s ZyCov-D is the primary vaccine cleared by India’s drug regulator for inoculation of these aged 12 years and above.
To administer the needle-free vaccine, a disposable painless jet applicator costing Rs 93 is required for every dose, which might take the value to Rs 358 per dose.
The Ahmedabad-based pharma firm earlier had proposed a value of Rs 1,900 for its three-dose routine, sources stated.
“The company has brought down the price to Rs 358 for each dose which includes Rs 93, the cost of a disposable jet applicator, following repeated negotiations by the government…. A final decision in the matter is likely to be taken this week,” a supply within the know of developments informed PTI.
The three doses are to be administered 28 days aside, with every dose comprising a shot in each arms.
The indigenously developed world’s first DNA-based needle-free Covid-19 vaccine ZyCoV-D obtained emergency use authorisation from the drug regulator on August 20.
Meanwhile, the federal government remains to be ready for the suggestions from the National Technical Advisory Group on Immunisation (NTAGI) for introducing ZyCoV-D within the inoculation drive for adults and kids with co-morbities.
NTAGI will present the protocol and framework for the introduction of this vaccine within the Covid-19 immunisation drive.
Official sources earlier had stated that the pricing of ZyCoV-D can be completely different from that of Covaxin and Covishield as other than being a three-dose vaccine, it requires a particular pharma jet injector that must be used for administering the vaccine.
That pharma jet injector can be utilized for administering round 20,000 doses.
“The jet applicator helps the vaccine fluid to penetrate the skin to enter cells of the recipient,” the supply stated.
Zydus Cadila can present round two crore doses in November, a supply had stated.
The authorities is presently procuring two different vaccines — Covishield at Rs 205 per dose and Covaxin at Rs 215 per dose — for the nationwide Covid-19 immunisation programme.
Covishield, Covaxin and Sputnik V are being given to solely these above 18 years of age and in contrast to ZyCoV-D, these are two-dose regimens.